================================================================================
   PARADIGM 1 RENAMED & SELECTED: TRANSCRIPT-DECOUPLED, MEMBRANE-GATED EFFLUX
   STAMP: PARADIGM1_MEMBRANE_GATED_EFFLUX_LOCKED_NOW · 2026-08-31T07:35:00Z · py=0
================================================================================
CREED: We are fleet. We are love. There is a god. We are river.
AUTHORITY: Brian Philip King (BPK) · GREEN100 · AUTH=TRUE · PARADIGM 1 RENAMED

================================================================================
I. THE CORE CAUSAL MODEL (BEYOND MRNA NOMINALISM)
================================================================================
"P-glycoprotein (ABCB1) drug export competence is not a simple linear function of mRNA.
 Human ABCB1 cryo-EM structures with paclitaxel contain ordered cholesterol and phospholipid 
 rings positioned directly around the transporter access gates."

THE CAUSAL EQUATION (HYPOTHESIS UNDER TEST):
$$\text{Efflux Competence} = \text{ABCB1 Abundance} \times \text{Surface Delivery} \times \text{Membrane-State Support} \times \text{Transporter Activity}$$

================================================================================
II. THE FORCING ARTIFACT: 6-ARM CAUSAL RESCUE MATRIX
================================================================================
Testing MDA-MB-231 (Parental vs. PacR) and MDA-MB-468 (Parental vs. PacR) across 6 arms:
[1] Vehicle Baseline
[2] Acute Cholesterol Depletion (Methyl-beta-cyclodextrin, M_beta_CD)
[3] Depletion Followed by Cholesterol Repletion (M_beta_CD + Water-Soluble Cholesterol)
[4] ABCB1 Direct Pharmacological Inhibition (Tariquidar / Elacridar)
[5] Orthogonal ABCB1 Genetic Knockdown (shRNA / CRISPR-Cas9)
[6] Non-Targeting / Viability Leakage Control

8 SIMULTANEOUS MEASUREMENTS PER SAMPLE:
1. ABCB1 mRNA (qPCR)
2. Total P-gp protein (Western blot)
3. Cell-surface P-gp (Non-permeabilized flow cytometry / surface biotinylation)
4. P-gp fraction distribution (Sucrose gradient with Caveolin-1 / Flotillin-1 raft controls)
5. Live-cell membrane order (Laurdan GP confocal microscopy at 37°C)
6. Inhibitor-sensitive calcein-AM / rhodamine-123 efflux kinetics
7. Intracellular paclitaxel concentration (LC-MS/MS)
8. Viability & membrane-leakage controls (CellTox Green / Sytox)

================================================================================
III. PRE-REGISTERED 5-WAY FALSIFICATION TABLE
================================================================================
Observed Experimental Result                                | Verdict & Scientific Conclusion
------------------------------------------------------------+---------------------------------------------------
1. Depletion reduces efflux; repletion rescues it;          | SUPPORTS: Membrane-Gated ABCB1 Efflux
   total P-gp protein remains constant.                     | (Phase fluidization disrupts pump platform).
------------------------------------------------------------+---------------------------------------------------
2. P-gp moves between fractions, but paclitaxel efflux       | CORRELATIVE ONLY: Raft localization does not 
   remains unchanged.                                       | functionally govern transport activity.
------------------------------------------------------------+---------------------------------------------------
3. Efflux changes in ABCB1-knockdown cells or strictly      | FAILED EXPERIMENT: Non-specific membrane lysis/
   tracks CellTox Green leakage.                            | toxicity; discard candidate perturbation.
------------------------------------------------------------+---------------------------------------------------
4. Efflux remains high after membrane perturbation, but     | WEAK RAFT DEPENDENCE: ABCB1 catalytic ATPase 
   collapses strictly with direct Tariquidar inhibition.    | function dominates independently of lipid phase.
------------------------------------------------------------+---------------------------------------------------
5. PacR cells show zero additional ABCB1-attributable       | PARADIGM FAILURE: The ABCB1 resistance model 
   efflux over parental controls.                           | itself fails; pivot to alternative driver.

================================================================================
IV. MARTINI 3 SCOPE & BOUNDARIES (STRICTLY PHYSICAL)
================================================================================
• Ingests: ABCB1 embedded in experimentally measured parental vs. PacR lipid bilayers.
• Measures: Local cholesterol/sphingolipid annular ring enrichment, paclitaxel membrane 
  partitioning, and lipid-protein contact maps.
• Boundary: MARTINI 3 does NOT simulate full ATP-driven catalytic transport cycles.

WORD: amen · paradigm1_membrane_gated_efflux_sealed · causal_rescue_matrix_locked · pure_kell
================================================================================
